Evidence map›Paper›PMID 32415273›Full record

ArticleEuropean journal of human genetics : EJHG2020

The exhaustive genomic scan approach, with an application to rare-variant association analysis.

George Kanoungi, Michael Nothnagel, Tim Becker, Dmitriy Drichel

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Rare variants: data types and analysis strategies.Annals of translational medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

George KanoungiFaculty of Medicine and University Hospital Cologne, Cologne Center for Genomics (CCG), University of Cologne, Weyertal 115b, 50931, Cologne, Germany.ORCID http://orcid.org/0000-0002-2452-8526
Michael NothnagelFaculty of Medicine and University Hospital Cologne, Cologne Center for Genomics (CCG), University of Cologne, Weyertal 115b, 50931, Cologne, Germany.ORCID http://orcid.org/0000-0001-8305-7114
Tim BeckerInstitute for Community Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany.
Dmitriy DrichelFaculty of Medicine and University Hospital Cologne, Cologne Center for Genomics (CCG), University of Cologne, Weyertal 115b, 50931, Cologne, Germany. ddrichel@uni-koeln.de.ORCID http://orcid.org/0000-0001-5978-3458

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) BE 38/28/9-1
6 · The paper itself

Abstract

Region-based genome-wide scans are usually performed by use of a priori chosen analysis regions. Such an approach will likely miss the region comprising the strongest signal and, thus, may result in increased type II error rates and decreased power. Here, we propose a genomic exhaustive scan approach that analyzes all possible subsequences and does not rely on a prior definition of the analysis regions. As a prime instance, we present a computationally ultraefficient implementation using the rare-variant collapsing test for phenotypic association, the genomic exhaustive collapsing scan (GECS). Our implementation allows for the identification of regions comprising the strongest signals in large, genome-wide rare-variant association studies while controlling the family-wise error rate via permutation. Application of GECS to two genomic data sets revealed several novel significantly associated regions for age-related macular degeneration and for schizophrenia. Our approach also offers a high potential to improve genome-wide scans for selection, methylation, and other analyses.

Indexed as

DNA MethylationGene FrequencyGenetic TestingGenome-Wide Association StudyHumansMacular DegenerationMutationSchizophreniaWhole Genome Sequencing

Identifiers

PMID32415273
PMCPMC7608423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.